The Minister of Pharmaceutical Industry oversaw the signing of a strategic cooperation agreement between Pharma Invest and the Chinese group Yangtze River Pharmaceutical. Attended by ministry officials and the head of the public group Saidal, the deal focuses on transferring advanced technologies for the production of pharmaceutical raw materials and supporting the manufacture of innovative medicines. Furthermore, the meeting established the framework for a forthcoming agreement between Saidal and Pharma Invest to collaborate on producing and distributing high-added-value drugs. The Minister emphasized that such initiatives are crucial for strengthening national health sovereignty and advancing the domestic industrial sector.